Evening with Dr Barry Feig (16 January 2020)
With the support of Credabl and Tego, we are pleased to inform you that Dr Barry Feig is coming to Sydney (NSW, Aus) to speak about neoadjuvant therapy for retroperitoneal sarcoma. We'd love if you can join us!
Details of the event below:
- Date: 16 January 2020 (Thursday)
- Time: 6.30pm - 9pm
- Venue: Bel & Brio (Barangaroo) - T3.01, 300 Barangaroo Avenue, Barangaroo Sydney NSW 2000
- Cost: $45 per person (includes a 3-course meal) - TBC
For those who can attend in person, kindly RSVP soonest by sending us an email (email@example.com).
Live Web Conferencing
If you live outside of Sydney but would like to watch to Dr Feig's talk, you can watch through live web conferencing (link) - this web conferencing link will go live at 7pm (Sydney time) on 16 January 2020. Dr Feig is scheduled to talk at 7.30pm.
Please let us know if you'd be joining us via web conferencing by sending us an email (firstname.lastname@example.org).
About Dr Barry Feig
Dr Feig is the immediate past Chief of the Surgical Sarcoma Section and a Professor in the Department of Surgical Oncology at the University of Texas, MD Anderson Cancer Center in Houston, Texas. He has been affiliated with MD Anderson since 1991. He received his medical degree from the State University of New York Health Science Center in Syracuse, New York. Following a Residency in General Surgery and a Research Fellowship at Northwestern University Medical School, Dr Feig went on to complete a Trauma Fellowship at the University of Minnesota Hospitals, and a Surgical Oncology Fellowship at the University of Texas, MD Anderson Cancer Center. His expertise and research interests include sarcoma and malignancies of the breast and gastrointestinal tract. As a leader in oncologic research, he has authored or co-authored over 200 publications in peer-review journals and has been the lead or co-author of many textbook chapters spanning all disciplines of oncology.